Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Core Viewpoint - Glancy Prongay & Murray LLP has initiated an investigation into aTyr Pharma Inc. regarding potential violations of federal securities laws, indicating possible legal challenges for the company and its investors [1]. Company Summary - aTyr Pharma Inc. is under scrutiny for its compliance with federal securities laws, which may affect investor confidence and the company's market performance [1]. - The investigation was announced following a significant event on September 15, which has not been detailed in the provided content but suggests a triggering incident for the inquiry [1].